Viatris
Search results
Viatris is a unique global healthcare company focused on a wide variety of therapeutic areas, empowering people worldwide by expanding their access to a broad range of trusted, quality medications, regardless of geography or circumstance.
Viatris produces high quality medicines across a broad range of therapeutic areas. Explore our brands, generics, biosimilars, over-the-counter products and API.
Viatris harnesses the power of numerous branded drugs, including 20 iconic brands as well as several global key brands. Learn more about our branded products.
Viatris is a global pharmaceutical company that believes in healthcare not as it is, but as it should be. Learn about our story, explore our products and browse career opportunities.
Viatris global portfolio comprises more than 1,400 molecules across a broad range of major therapeutic areas, including best-in-class, iconic brand-name products, as well as global key brands, generics, including branded and complex generics, biosimilars and over-the-counter offerings.
Our global portfolio, supported by our science, medical and manufacturing expertise, delivers global iconic and key brands, biosimilars, generics - including complex and branded generics - and over-the-counter products.
Viatris offers quality treatment options across more than 10 major therapeutic areas covering a wide variety of noncommunicable and infectious diseases. We also offer support services such as diagnostic clinics, educational seminars and digital tools to help patients better manage their health.
We offer a broad and diverse range of treatment options across all our therapeutic areas, with many categories containing several products in a range of dosage forms, formulations and delivery systems that allow physicians to tailor care for optimal treatment.
Find a Mylan Product. Search our catalog of medicines and products or view our full product list >
At Viatris, we provide access at scale. We are a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally.
